Back to top
more

Universal Health Services (UHS)

(Delayed Data from NYSE)

$166.06 USD

166.06
965,423

+0.96 (0.58%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $165.82 -0.24 (-0.14%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 7% (18 out of 252)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Factors Setting the Tone for Ecolab's (ECL) Q1 Earnings

by Zacks Equity Research

Ecolab's (ECL) first-quarter results are likely to reflect continued segmental strength.

Centene (CNC) Q1 Earnings Beat on Premiums, '24 EPS View Hiked

by Zacks Equity Research

Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.

Should Value Investors Buy Universal Health Services (UHS) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Universal Health (UHS) Q1 Earnings Beat on Rising Patient Days

by Zacks Equity Research

Universal Health's (UHS) first-quarter results benefit from improved patient days in both segments. However, higher expenses partially offset the positives.

Compared to Estimates, Universal Health Services (UHS) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Universal Health Services (UHS) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Universal Health Services (UHS) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Universal Health Services (UHS) delivered earnings and revenue surprises of 17.83% and 1.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat

by Zacks Equity Research

Humana (HUM) bumps up individual Medicare Advantage membership growth guidance.

Debasmita Chatterjee headshot

Watch These 5 Medical Stocks for Q1 Earnings: Beat or Miss?

by Debasmita Chatterjee

Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.

Exploring Analyst Estimates for Universal Health Services (UHS) Q1 Earnings, Beyond Revenue and EPS

by Zacks Equity Research

Evaluate the expected performance of Universal Health Services (UHS) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Should You Buy HCA Healthcare (HCA) Ahead of Q1 Earnings?

by Zacks Equity Research

HCA Healthcare's (HCA) first-quarter results are likely to reflect increased admissions and patient days.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?

by Zacks Equity Research

Universal Health's (UHS) Q1 results are expected to be aided by growing patient volumes and surgical cases, partly offset by increased expenses.

Will Humana (HUM) Q1 Earnings Beat on CenterWell Strength?

by Zacks Equity Research

Humana's (HUM) first-quarter results are likely to reflect rising premiums and investment income.

HCA Healthcare (HCA) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nalak Das headshot

5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings

by Nalak Das

We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.

Will High Medical Care Ratios Hurt Molina's (MOH) Q1 Earnings?

by Zacks Equity Research

Molina's (MOH) first-quarter performance is likely to have been hurt by escalating medical care costs, partly offset by growing membership in all three businesses.

Elevance (ELV) Q1 Earnings Beat on Rate Hikes, Guidance Raised

by Zacks Equity Research

Elevance Health (ELV) has a leftover capacity of around $3.6 billion under its share buyback authorization.

Will Low Patient Days Impact Community Health (CYH) Q1 Earnings?

by Zacks Equity Research

Community Health's (CYH) first-quarter results are likely to reflect declining beds in services and adjusted admissions.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Universal Health Services (UHS) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Universal Health Services (UHS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UnitedHealth Group (UNH) Tops on Q1 Earnings, Reaffirms EPS View

by Zacks Equity Research

UnitedHealth Group (UNH) first-quarter earnings benefit from strong Optum and UnitedHealthcare business lines. Rising expenses partially offset the positives.

Will Elevance (ELV) Beat Q1 Earnings on Carelon Strength?

by Zacks Equity Research

The first-quarter results of Elevance (ELV) are likely to reflect higher product revenues and Commercial Individual membership growth.

Can High Medical Costs Affect UnitedHealth's (UNH) Q1 Earnings?

by Zacks Equity Research

UnitedHealth's (UNH) first-quarter results are likely to reflect growth in premium levels and service revenues.

Acadia Healthcare (ACHC) Opens Facility to Address Mental Health

by Zacks Equity Research

Acadia Healthcare (ACHC) inaugurates an acute care hospital in Mesa, AZ, to cater to patients struggling with addiction and mental health issues in the area.

Will UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q1 Earnings?

by Zacks Equity Research

UnitedHealth's (UNH) first-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues and the number of people it served.